219 related articles for article (PubMed ID: 27481196)
1. [Matrix Gla protein as natural inhibitor of vascular calcification and potential treatment target].
Mayer O
Cas Lek Cesk; 2016; 155(4):13-6. PubMed ID: 27481196
[TBL] [Abstract][Full Text] [Related]
2. The role of vitamin K in vascular calcification of patients with chronic kidney disease.
Wuyts J; Dhondt A
Acta Clin Belg; 2016 Dec; 71(6):462-467. PubMed ID: 27254816
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K for the Treatment of Cardiovascular Disease in End-Stage Renal Disease Patients: Is there Hope?
Roumeliotis S; Roumeliotis A; Dounousi E; Eleftheriadis T; Liakopoulos V
Curr Vasc Pharmacol; 2021; 19(1):77-90. PubMed ID: 32196451
[TBL] [Abstract][Full Text] [Related]
4. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization.
Schurgers LJ; Uitto J; Reutelingsperger CP
Trends Mol Med; 2013 Apr; 19(4):217-26. PubMed ID: 23375872
[TBL] [Abstract][Full Text] [Related]
5. Vitamin K Supplementation for the Prevention of Cardiovascular Disease: Where Is the Evidence? A Systematic Review of Controlled Trials.
Vlasschaert C; Goss CJ; Pilkey NG; McKeown S; Holden RM
Nutrients; 2020 Sep; 12(10):. PubMed ID: 32977548
[TBL] [Abstract][Full Text] [Related]
6. Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review.
Roumeliotis S; Dounousi E; Eleftheriadis T; Liakopoulos V
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717170
[TBL] [Abstract][Full Text] [Related]
7. Prevention of vasculopathy by vitamin K supplementation: can we turn fiction into fact?
Brandenburg VM; Schurgers LJ; Kaesler N; Püsche K; van Gorp RH; Leftheriotis G; Reinartz S; Koos R; Krüger T
Atherosclerosis; 2015 May; 240(1):10-6. PubMed ID: 25744701
[TBL] [Abstract][Full Text] [Related]
8. [The matrix-gla protein awakening may lead to the demise of vascular calcification].
Delanaye P; Liabeuf S; Bouquegneau A; Cavalier É; Massy ZA
Nephrol Ther; 2015 Jul; 11(4):191-200. PubMed ID: 25794931
[TBL] [Abstract][Full Text] [Related]
9. The Role of Matrix Gla Protein (MGP) in Vascular Calcification.
Bjørklund G; Svanberg E; Dadar M; Card DJ; Chirumbolo S; Harrington DJ; Aaseth J
Curr Med Chem; 2020; 27(10):1647-1660. PubMed ID: 30009696
[TBL] [Abstract][Full Text] [Related]
10. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.
Westenfeld R; Krueger T; Schlieper G; Cranenburg EC; Magdeleyns EJ; Heidenreich S; Holzmann S; Vermeer C; Jahnen-Dechent W; Ketteler M; Floege J; Schurgers LJ
Am J Kidney Dis; 2012 Feb; 59(2):186-95. PubMed ID: 22169620
[TBL] [Abstract][Full Text] [Related]
11. Is Matrix Gla Protein Associated with Vascular Calcification? A Systematic Review.
Barrett H; O'Keeffe M; Kavanagh E; Walsh M; O'Connor EM
Nutrients; 2018 Mar; 10(4):. PubMed ID: 29584693
[TBL] [Abstract][Full Text] [Related]
12. Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system.
Viegas CS; Rafael MS; Enriquez JL; Teixeira A; Vitorino R; Luís IM; Costa RM; Santos S; Cavaco S; Neves J; Macedo AL; Willems BA; Vermeer C; Simes DC
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):399-408. PubMed ID: 25538207
[TBL] [Abstract][Full Text] [Related]
13. Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol.
Krueger T; Schlieper G; Schurgers L; Cornelis T; Cozzolino M; Jacobi J; Jadoul M; Ketteler M; Rump LC; Stenvinkel P; Westenfeld R; Wiecek A; Reinartz S; Hilgers RD; Floege J
Nephrol Dial Transplant; 2014 Sep; 29(9):1633-8. PubMed ID: 24285427
[TBL] [Abstract][Full Text] [Related]
14. Vitamin K status and vascular calcification: evidence from observational and clinical studies.
Shea MK; Holden RM
Adv Nutr; 2012 Mar; 3(2):158-65. PubMed ID: 22516723
[TBL] [Abstract][Full Text] [Related]
15. The role of vitamin K in soft-tissue calcification.
Theuwissen E; Smit E; Vermeer C
Adv Nutr; 2012 Mar; 3(2):166-73. PubMed ID: 22516724
[TBL] [Abstract][Full Text] [Related]
16. The effect of vitamin K2 supplementation on vascular calcification in haemodialysis patients: a 1-year follow-up randomized trial.
Oikonomaki T; Papasotiriou M; Ntrinias T; Kalogeropoulou C; Zabakis P; Kalavrizioti D; Papadakis I; Goumenos DS; Papachristou E
Int Urol Nephrol; 2019 Nov; 51(11):2037-2044. PubMed ID: 31529295
[TBL] [Abstract][Full Text] [Related]
17. Should vitamin K be supplemented instead of antagonised in patients with idiopathic pulmonary fibrosis?
De Brouwer B; Piscaer I; Von Der Thusen JH; Grutters JC; Schutgens RE; Wouters EF; Janssen R
Expert Rev Respir Med; 2018 Mar; 12(3):169-175. PubMed ID: 29303380
[TBL] [Abstract][Full Text] [Related]
18. Matrix Gla-protein: the calcification inhibitor in need of vitamin K.
Schurgers LJ; Cranenburg EC; Vermeer C
Thromb Haemost; 2008 Oct; 100(4):593-603. PubMed ID: 18841280
[TBL] [Abstract][Full Text] [Related]
19. Extrahepatic Vitamin K-Dependent Gla-Proteins-Potential Cardiometabolic Biomarkers.
Galunska B; Yotov Y; Nikolova M; Angelov A
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542487
[TBL] [Abstract][Full Text] [Related]
20. Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study.
Caluwé R; Vandecasteele S; Van Vlem B; Vermeer C; De Vriese AS
Nephrol Dial Transplant; 2014 Jul; 29(7):1385-90. PubMed ID: 24285428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
